Insider Trading Activity Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) – Insider Bought 2,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)

Martin J Driscoll , Insider of Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) reportedly Bought 2,000 shares of the company’s stock at an average price of 12.36 for a total transaction amount of $24,720.00 SEC Form

Insider Trading History For Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)

  • On 5/11/2016 Martin J Driscoll, CEO, bought 12,500 with an average share price of $12.00 per share and the total transaction amounting to $150,000.00.View SEC Filing
  • On 5/11/2016 Kurt M Eichler, Director, bought 41,666 with an average share price of $12.00 per share and the total transaction amounting to $499,992.00.View SEC Filing
  • On 8/4/2016 Martin J Driscoll, Insider, bought 2,000 with an average share price of $9.96 per share and the total transaction amounting to $19,920.00.View SEC Filing
  • On 8/4/2016 Jonathan Freve, CFO, bought 1,000 with an average share price of $9.75 per share and the total transaction amounting to $9,750.00.View SEC Filing
  • On 8/9/2016 Martin J Driscoll, Insider, bought 2,000 with an average share price of $11.03 per share and the total transaction amounting to $22,060.00.View SEC Filing
  • On 8/12/2016 Nezam H Afdhal, Insider, bought 2,600 with an average share price of $11.33 per share and the total transaction amounting to $29,458.00.View SEC Filing
  • On 8/16/2016 Nezam H Afdhal, Insider, bought 1,900 with an average share price of $11.43 per share and the total transaction amounting to $21,717.00.View SEC Filing

    • Analyst Ratings For Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)
    These are 1 Hold Rating, 4 Buy Ratings .
    The current consensus rating for Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) is Buy (Score: 2.80) with a consensus target price of $26.25 , a potential (107.51% upside)

    Analyst Ratings History For Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)

    • On 8/19/2016 William Blair Initiated Coverage of rating Outperform with a price target of $26.00
    • On 11/6/2016 Dawson James Reiterated Rating Buy
    • On 5/19/2017 JMP Securities Initiated Coverage of rating Mkt Outperform to Market Perform with a price target of $20.00
    • On 7/19/2017 Cantor Fitzgerald Initiated Coverage of rating Overweight to Overweight with a price target of $29.00
    • On 8/1/2017 Chardan Capital Lower Price Target of rating Buy to Buy with a price target of $34.00 to $30.00

    Recent Trading Activity for Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)
    Shares of Spring Bank Pharmaceuticals, Inc. closed the previous trading session at 12.65 down -0.02 -0.16% with 46,249 shares trading hands.